Noom Med Pricing (2026): every published tier
Noom Med currently charges $79 first month, then $199/mo (4-week starter, then $199/mo billed quarterly). This figure has not yet been machine-verified on their live site; treat it as reported.
Every published Noom Med price
| Tier | Price | What that number means |
|---|---|---|
| Microdose GLP-1Rx (starter) | $79/mo | First 4-week supply. Low-dose GLP-1, all-inclusive: clinical care, medication and the digital program. Verified 2026-07-27 |
| Microdose GLP-1Rx (ongoing) | $199/mo | $199/mo after the first 4-week supply, billed quarterly. Verified 2026-07-27 |
| GLP-1Rx Program | $249/mo | $129 to start, then $249/mo billed quarterly. Verified 2026-07-27 |
| GLP-1Rx Plus Program | $299/mo | $149 to start, then $299/mo billed quarterly. Activates GLP-1 and GIP receptors. Verified 2026-07-27 |
| Weight Loss Pill (metformin, NOT a GLP-1) | $99/mo | $69 to start, then $99/mo billed quarterly. Oral metformin, not a GLP-1 receptor agonist. Verified 2026-07-27 |
Noom Med pricing questions
Do I have to use the coaching features?
Technically no, but the coaching is the core value proposition of Noom Med. If you mainly want medication access, compare [GobyMeds](/reviews/gobymeds), which advertises programs from $99/mo without a separate membership fee, and verify the prescribed product and checkout total. MEDVi advertises $179 for the first semaglutide month and $299 refills, but FDA warning letter #721455 is part of its record; compare the ongoing price and warning context before choosing.
What insurance plans does Noom Med accept?
Noom Med works with most major commercial insurance plans for the medication component. The coaching component is included in the subscription regardless of insurance.
Full context, including who Noom Med is actually for: our independent Noom Med review.
How this price sits against all 54 programs we track: the cheapest verified GLP-1 programs and the machine-readable price index.
Comparing by molecule instead: semaglutide pricing across all providers.
Comparing by molecule instead: tirzepatide pricing across all providers.
Comparing by molecule instead: Wegovy access and pricing.
Comparing by molecule instead: Zepbound access and pricing.